SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-19-004113
Filing Date
2019-04-10
Accepted
2019-04-10 16:03:27
Documents
5
Period of Report
2019-05-23
Effectiveness Date
2019-04-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A aerieproxy2019.htm DEF 14A 1225090
2 aeriestockpricea01.jpg GRAPHIC 55385
3 aerilogoa02.jpg GRAPHIC 48344
4 signature1a02.jpg GRAPHIC 7059
5 signature2a02.jpg GRAPHIC 10599
  Complete submission text file 0001628280-19-004113.txt   1383013
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36152 | Film No.: 19741716
SIC: 2836 Biological Products, (No Diagnostic Substances)